UMIN ID: UMIN000001792
Registered date:24/03/2009
Effect of landiolol hydrochloride for prevention of atrial fibrillation after CABG: a randomised controlled trial
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | myocardial infarction, angina |
Date of first enrollment | 2008/10/01 |
Target sample size | 140 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | intra-and perioperative administration of landiolol hydrochloride intra-and perioperative non-administration of landiolol hydrochloride |
Outcome(s)
Primary Outcome | Incidence of postoperative atrial fibrillation |
---|---|
Secondary Outcome | 1) age 2) Blood pressure, heart rate, CVP 3) IL-6, IL-8 4) CK-MB, Tp-I, H-FABP 5) Urinary-OHdG 6) hyaluronan, KL-6, angiotensin-II 7) mortality, complication |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 90years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | past of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen |
Related Information
Primary Sponsor | Nihon University school of medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | self funding |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Japan |
Telephone | |
Affiliation | Nihon University School of Medicine Department of Cardiovascular Surgery |
scientific contact | |
Name | Akira Sezai |
Address | 30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan Japan |
Telephone | 03-3972-8111 |
Affiliation | Nihon University school of medicine Department of Cardiovascular Surgery |